Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine for Renal Protection in Septic Shock (TRPSS)
NCT03550794Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Sep 2018
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiamine in septic shock, acute kidney injury (AKI), sponsored by Beth Israel Deaconess Medical Center. Started Sep 2018; status: completed.
02
Drugs
thiamine
03
Conditions
septic shockacute kidney injury (AKI)
Beyond the preview
Go deeper on NCT03550794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03550794.